Stay updated with breaking news from Promising Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
—Proteomic Analysis of Human Samples Highlights the Unique Role of CCL24 in Activating Key PSC-related Disease Mechanisms Involving Immune Cell Trafficking and HSC Activation, Further Confirming the Potential of Chemomab's
Independent biopharmaceutical company Specialised Therapeutics Asia Pte Ltd (ST) has signed a license deal with Korea-based CanariaBio Inc., acquiring the exclusive license to a new monoclonal antibody therapy for patients with ovarian cancer in Australia, New Zealand and in select Southeast Asian countries.
Breast cancer is one of the most common cancers. Boron clusters containing boron atoms are being touted as promising therapeutics for breast cancer.